Cytosorbents

CTSO · NASDAQ

$5.32+$0.36 (+7.26%)TodayMarket closed · Oct 20, 7:47 PM ET

Prev close $4.96

Latest news

NewsOct 19, 1:05 PM ET
12 Health Care Stocks Moving In Monday's Intraday Session
NewsOct 16, 1:05 PM ET
12 Health Care Stocks Moving In Friday's Intraday Session
Press releaseSep 30, 7:00 AM ETPRNewswire
CytoSorbents Announces New Data Presentations at Upcoming International Conferences in Cardiac Surgery and Critical Care
Press releaseSep 23, 7:00 AM ETPRNewswire
CytoSorbents Regains Compliance with Nasdaq Minimum Bid Price Requirement
Press releaseSep 10, 7:00 AM ETPRNewswire
CytoSorbents to Present at the H.C. Wainwright 28th Annual Global Investment Conference
Press releaseSep 3, 7:00 AM ETPRNewswire
CytoSorbents Announces Reverse Stock Split
Press releaseSep 2, 7:28 AM ETPRNewswire
CytoSorbents Announces New Real-World Data Demonstrating Significant Reduction in Severe Bleeding Using CytoSorb in CABG Patients on Ticagrelor and Updates Recent DrugSorb-ATR FDA Pre-Submission Meetings
NewsAug 20, 5:06 PM ET
12 Health Care Stocks Moving In Thursday's After-Market Session
NewsAug 11, 5:06 PM ET
12 Health Care Stocks Moving In Tuesday's After-Market Session
Press releaseAug 6, 4:25 PM ETPRNewswire
CytoSorbents Reports Second Quarter 2026 Financial Results, Recent Business Highlights, and Regulatory Update
Press releaseJul 20, 7:00 AM ETPRNewswire
CytoSorbents to Report Second Quarter 2026 Financial Results and Recent Business Highlights
Press releaseJun 18, 8:46 AM ETGlobe Newswire
CytoSorbents to Present at the Life Sciences Forum on June 24, 2026 and Meet Virtually with Investors on June 30, 2026
NewsMay 13, 5:36 PM ET
Transcript: CytoSorbents Q1 2026 Earnings Conference Call
Press releaseMay 13, 4:00 PM ETPRNewswire
CytoSorbents Reports First Quarter 2026 Financial Results, Recent Business Highlights, and Regulatory Update
NewsMay 13, 7:11 AM ET
Earnings Scheduled For May 13, 2026
Press releaseApr 30, 7:00 AM ETPRNewswire
CytoSorbents to Report First Quarter 2026 Financial Results and Recent Business Highlights
Press releaseMar 25, 4:05 PM ETPRNewswire
CytoSorbents Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights
NewsMar 25, 7:11 AM ET
Earnings Scheduled For March 25, 2026
Press releaseMar 19, 9:44 AM ETPRNewswire
CytoSorbents Announces HotSwap™ Launch, Renewed Aferetica Partnership, and New Clinical Evidence at ISICEM 2026
Press releaseMar 5, 7:00 AM ETPRNewswire
CytoSorbents to Report Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights
NewsJan 13, 1:12 PM ET
Watching Cytosorbents; Zacks Small-Cap Research Gives Stock $5 Price Valuation
NewsJan 12, 9:00 AM ET
What Analysts Are Saying About CytoSorbents Stock
Press releaseJan 12, 7:00 AM ETPRNewswire
CytoSorbents Reports Preliminary Unaudited Fourth Quarter and Full-Year 2025 Results and Business Update
Press releaseDec 10, 7:00 AM ETPRNewswire
CytoSorbents to Participate in a Virtual Fireside Chat with D. Boral Capital on Monday, December 15, 2025
Press releaseNov 17, 5:42 PM ETPRNewswire
Updated: CytoSorbents to Present at the Jefferies Global Healthcare Conference in London
Press releaseNov 13, 4:05 PM ETPRNewswire
CytoSorbents Reports Third Quarter 2025 Financial Results and Provides Business Update
Press releaseNov 11, 7:00 AM ETPRNewswire
CytoSorbents to Participate at the Jefferies Global Healthcare Conference in London
Press releaseOct 30, 7:00 AM ETPRNewswire
CytoSorbents to Report Third Quarter 2025 Financial Results and Recent Business Highlights
Press releaseOct 28, 7:00 AM ETPRNewswire
In Memoriam: Dr. Robert Hawes Bartlett (1939-2025) - Father of Extracorporeal Membrane Oxygenation (ECMO) and Former CytoSorbents Chief Medical Officer
Press releaseSep 29, 7:00 AM ETPRNewswire
CytoSorbents to Showcase Pioneering New Cardiac Surgery Data in Key Applications at the EACTS 2025 Annual Meeting in Copenhagen
NewsSep 16, 10:01 AM ET
Deep Dive Into CytoSorbents Stock: Analyst Perspectives (5 Ratings)
Press releaseSep 16, 7:00 AM ETPRNewswire
CytoSorbents Provides DrugSorb-ATR Regulatory Update
Press releaseSep 8, 7:00 AM ETPRNewswire
CytoSorbents To Host Global Webinar on "Turning the Tide in Sepsis and Septic Shock: Real World Insights with CytoSorb" in Recognition of World Sepsis Day
Press releaseSep 5, 7:00 AM ETPRNewswire
CytoSorbents to Present at the H.C. Wainwright 27th Annual Global Investment Conference
NewsAug 20, 8:08 AM ET
12 Health Care Stocks Moving In Wednesday's Pre-Market Session

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.

Latest news

12 Health Care Stocks Moving In Monday's Intraday Session

12 Health Care Stocks Moving In Friday's Intraday Session

CytoSorbents Announces New Data Presentations at Upcoming International Conferences in Cardiac Surgery and Critical Care

CytoSorbents Regains Compliance with Nasdaq Minimum Bid Price Requirement

CytoSorbents to Present at the H.C. Wainwright 28th Annual Global Investment Conference

CytoSorbents Announces Reverse Stock Split

CytoSorbents Announces New Real-World Data Demonstrating Significant Reduction in Severe Bleeding Using CytoSorb in CABG Patients on Ticagrelor and Updates Recent DrugSorb-ATR FDA Pre-Submission Meetings

12 Health Care Stocks Moving In Thursday's After-Market Session

12 Health Care Stocks Moving In Tuesday's After-Market Session

CytoSorbents Reports Second Quarter 2026 Financial Results, Recent Business Highlights, and Regulatory Update

CytoSorbents to Report Second Quarter 2026 Financial Results and Recent Business Highlights

CytoSorbents to Present at the Life Sciences Forum on June 24, 2026 and Meet Virtually with Investors on June 30, 2026

Transcript: CytoSorbents Q1 2026 Earnings Conference Call

CytoSorbents Reports First Quarter 2026 Financial Results, Recent Business Highlights, and Regulatory Update

Earnings Scheduled For May 13, 2026

CytoSorbents to Report First Quarter 2026 Financial Results and Recent Business Highlights

CytoSorbents Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights

Earnings Scheduled For March 25, 2026

CytoSorbents Announces HotSwap™ Launch, Renewed Aferetica Partnership, and New Clinical Evidence at ISICEM 2026

CytoSorbents to Report Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights

Watching Cytosorbents; Zacks Small-Cap Research Gives Stock $5 Price Valuation

What Analysts Are Saying About CytoSorbents Stock

CytoSorbents Reports Preliminary Unaudited Fourth Quarter and Full-Year 2025 Results and Business Update

CytoSorbents to Participate in a Virtual Fireside Chat with D. Boral Capital on Monday, December 15, 2025

Updated: CytoSorbents to Present at the Jefferies Global Healthcare Conference in London

CytoSorbents Reports Third Quarter 2025 Financial Results and Provides Business Update

CytoSorbents to Participate at the Jefferies Global Healthcare Conference in London

CytoSorbents to Report Third Quarter 2025 Financial Results and Recent Business Highlights

In Memoriam: Dr. Robert Hawes Bartlett (1939-2025) - Father of Extracorporeal Membrane Oxygenation (ECMO) and Former CytoSorbents Chief Medical Officer

CytoSorbents to Showcase Pioneering New Cardiac Surgery Data in Key Applications at the EACTS 2025 Annual Meeting in Copenhagen

Deep Dive Into CytoSorbents Stock: Analyst Perspectives (5 Ratings)

CytoSorbents Provides DrugSorb-ATR Regulatory Update

CytoSorbents To Host Global Webinar on "Turning the Tide in Sepsis and Septic Shock: Real World Insights with CytoSorb" in Recognition of World Sepsis Day

CytoSorbents to Present at the H.C. Wainwright 27th Annual Global Investment Conference

12 Health Care Stocks Moving In Wednesday's Pre-Market Session